Private-RX Limited - Accounts to registrar (filleted) - small 22.3

Private-RX Limited - Accounts to registrar (filleted) - small 22.3


IRIS Accounts Production v22.4.0.132 05240699 director 1.4.21 31.3.22 31.3.22 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure052406992021-03-31052406992022-03-31052406992021-04-012022-03-31052406992020-03-31052406992020-04-012021-03-31052406992021-03-3105240699ns16:EnglandWales2021-04-012022-03-3105240699ns15:PoundSterling2021-04-012022-03-3105240699ns11:Director12021-04-012022-03-3105240699ns11:PrivateLimitedCompanyLtd2021-04-012022-03-3105240699ns11:SmallEntities2021-04-012022-03-3105240699ns11:AuditExempt-NoAccountantsReport2021-04-012022-03-3105240699ns11:SmallCompaniesRegimeForDirectorsReport2021-04-012022-03-3105240699ns11:SmallCompaniesRegimeForAccounts2021-04-012022-03-3105240699ns11:FullAccounts2021-04-012022-03-3105240699ns11:RegisteredOffice2021-04-012022-03-3105240699ns6:ShareCapital2022-03-3105240699ns6:ShareCapital2021-03-31
REGISTERED NUMBER: 05240699 (England and Wales)







UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2022

FOR

PRIVATE-RX LIMITED

PRIVATE-RX LIMITED (REGISTERED NUMBER: 05240699)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2022










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


PRIVATE-RX LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2022







DIRECTOR: T A Farana





REGISTERED OFFICE: The Old Fire Station
69 Albion Street
Birmingham
B1 3EA





REGISTERED NUMBER: 05240699 (England and Wales)





ACCOUNTANTS: Prime
Chartered Accountants
161 Newhall Street
Birmingham
B3 1SW

PRIVATE-RX LIMITED (REGISTERED NUMBER: 05240699)

BALANCE SHEET
31 MARCH 2022

2022 2021
£    £   
CURRENT ASSETS
Cash at bank 1 1
TOTAL ASSETS LESS CURRENT
LIABILITIES

1

1

CAPITAL AND RESERVES
Called up share capital 1 1
SHAREHOLDERS' FUNDS 1 1

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2022 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 15 December 2022 and were signed by:





T A Farana - Director


PRIVATE-RX LIMITED (REGISTERED NUMBER: 05240699)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2022


1. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements for the year ended 31 March 2017 are the first financial statements that comply with the provisions of Section 1A of FRS 102. The transition date is 1 April 2015. On transition the prior year financial statements have not been restated as the directors do not consider the transitional adjustments to be material to the financial statements.

The company was dormant throughout the current year and previous period.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

2. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2021 - NIL).

3. ULTIMATE CONTROLLING PARTY

The company was controlled throughout the year by Mr T. Farana, director and majority shareholder of the Halcyon International Group Limited, the ultimate parent company.